Table 2.
Nanomaterials | Biomarkers | Recognition element | Limit of detection | Sample | References |
---|---|---|---|---|---|
AuNPs | Aβ40 | – | 0.23 nM | Human serum | [99] |
ZnO–Co3O4 nanocages | Aβ40 | – | 3.5 nM | Rat CSF | [102] |
Metal ion conjugated MnO2 nanosheet | Aβ species | – | 0.44 pM | Human blood | [104] |
AuNPs | AβO | Aptamer | 0.56 nM | aCSF | [107] |
pA-pT-apt@AuNPs | AβO | Aptamer | 3.03 nM | aCSF | [108] |
AgNPs, AuNPs | Aβ40, Aβ42 | – | – | Human plasma | [109] |
Gelsolin modified AgNTs and AgNRs | Aβ40, Aβ42 | – | – | Rat CSF and brain tissue | [111] |
Abbreviations: aCSF: artificial cerebrospinal fluid, AgNPs: silver nanoparticles, AgNRs: silver nanorods, AgNTs: silver nanotriangles, AuNPs: gold nanoparticles, pA-pT-apt@AuNPs: aptamer-polythymine-polyadenine-gold nanoparticles, PBAS: polyvalent biotinylated aptamer scaffold.